Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol

[1]  P. Seth,et al.  Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018 , 2020, MMWR. Morbidity and mortality weekly report.

[2]  Ellsworth M. Campbell,et al.  Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018. , 2019, American journal of public health.

[3]  A. Fauci,et al.  Opioids and Infectious Diseases: A Converging Public Health Crisis. , 2019, The Journal of infectious diseases.

[4]  Robert W Eisinger,et al.  HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. , 2019, JAMA.

[5]  W. Schaffner,et al.  Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  W. Miller,et al.  Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C , 2018, Current HIV/AIDS Reports.

[7]  Sarah J. Reed,et al.  An Exploration of Syndemic Factors That Influence Engagement in HIV Care Among Black Men , 2018, Qualitative health research.

[8]  Lawrence Scholl,et al.  Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017 , 2018, MMWR. Morbidity and mortality weekly report.

[9]  Publisher's Note , 2018, Anaesthesia.

[10]  D. Lewer,et al.  Opiate Injection–Associated Skin, Soft Tissue, and Vascular Infections, England, UK, 1997–2016 , 2017, Emerging infectious diseases.

[11]  T. Heeren,et al.  HIV-infected individuals who use alcohol and other drugs, and virologic suppression , 2017, AIDS care.

[12]  K. Ruggles,et al.  Sexual Risk and Transmission Behaviors, Partnerships and Settings Among Young Adult Nonmedical Opioid Users in New York City , 2017, AIDS and Behavior.

[13]  Michael W. Spiller,et al.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. , 2016, The New England journal of medicine.

[14]  C. del Rio,et al.  Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. , 2016, JAMA.

[15]  G. Bobashev,et al.  Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users , 2016, The American journal of drug and alcohol abuse.

[16]  A. Karchmer,et al.  Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective Endocarditis. , 2016, The American journal of medicine.

[17]  R. Durvasula,et al.  Substance Abuse Treatment in Persons with HIV/AIDS: Challenges in Managing Triple Diagnosis , 2014, Behavioral medicine.

[18]  F. Altice,et al.  Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Montaner,et al.  Barriers to HIV treatment among people who use injection drugs: implications for ‘treatment as prevention’ , 2012, Current opinion in HIV and AIDS.

[20]  G. Woody,et al.  Addiction Severity Index , 2012 .

[21]  S. Strathdee,et al.  Adherence to Antiretroviral Therapy Among HIV-Infected Drug Users: A Meta-Analysis , 2010, AIDS and Behavior.

[22]  D. Shepard,et al.  Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward , 2010, The Lancet.

[23]  V. Soriano,et al.  Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs , 2010, The Lancet.

[24]  Robert J. Volk,et al.  Effectiveness of the AUDIT-C as a Screening Test for Alcohol Misuse in Three Race/Ethnic Groups , 2008, Journal of General Internal Medicine.

[25]  C. Cunningham,et al.  Barriers to Obtaining Waivers to Prescribe Buprenorphine for Opioid Addiction Treatment Among HIV Physicians , 2007, Journal of General Internal Medicine.

[26]  K. Lynch,et al.  Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. , 2005, Archives of internal medicine.

[27]  J. Enders,et al.  Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.

[28]  B. Oldfield,et al.  Integration of care for HIV and opioid use disorder. , 2019, AIDS.